Wplyw zawartosci weglowodanow w dawce pokarmowej na farmakokinetyke antypiryny u cielat mieszancow rasy czarno-bialej i holsztynsko-fryzyjskiej

• Autorzy: Janus K , Posieczek L. , Muszczynski Z. , Antoszek J. , Suszycki S.

Warianty tytułu

EN

Effect of carbohydrate content in food ration on the pharmacokinetics of antipyrine in black-and-white x Holstein-Friesian cross-breed calves

• Języki publikacji: PL

Abstrakty

EN

The aim of this study was to determine the effect of breed on the changes of antipyrine pharmacokinetics in calves receiving high-carbohydrate food. The experiment was carried out on 40 calves (bulls) cross-breed (20 calves - 25% HF and 20 calves 75% HF) 20 animals in the control group and 20 animals in the experimental group. During the experiment the calves from the control group were fed a food ration containing: 250 g of protein, 400 g of carbohydrates and 250 g of lipids. The calves from the experimental group received the high-carbohydrate food: 250 g of protein, 500 g of carbohydrates and 250 g of lipids. The antipyrine test in the experimental group was carried out at 0 and 7 days after administering the food ration with the carbohydrate supplement. The pharmacokinetics of the model drug was calculated based on the plasma concentration (C) versus time (t) curves (TopFit 2.0 software). Statistical analysis was performed by a paired Student-t-test. The increase of carbohydrate content in food rations did not significantly influence the volume of distribution (Vd) of antipyrine in comparison to the control group. We observed, however, a significant (P<0.01) increase of biological half-life, t₀,₅, and a decrease of metabolic clearance (Clm) of antipyrine in calves receiving high-carbohydrate food. The obtained results indicated that calves receiving the high-carbohydrate food were slower metabolizers of antipyrine, but the genotype had no influence on this process (inhibition of activity enzymes of MFO-CYP450 complex) which is evidenced by statistically insignificant differences of pharmacokinetics parameters of antipyrine between 25% and 75% HF cross-breed calves.

Słowa kluczowe

PL

zawartosc weglowodanow; bydlo; farmakokinetyka; genotyp; antypiryna; dawki pokarmowe; cieleta; mieszance dwurasowe

• Wydawca: -
• Czasopismo: Medycyna Weterynaryjna
• Rocznik: 2007
• Tom: 63
• Numer: 03
• Opis fizyczny: s.353-356,tab.,bibliogr.

Twórcy

autor

Janus K

• Akademia Rolnicza, ul.Doktora Judyma 2, 71-466 Szczecin

autor

Posieczek L.

autor

Muszczynski Z.

autor

Antoszek J.

autor

Suszycki S.

Bibliografia

• 1.Alvares A. P., Anderson K. E., Conney A. H.: Interactions between nutritional factors and drug biotransformation in man. Proc. Natl. Acad. Sci. 1986, 74, 2501-2504.
• 2.Anderson K. E., Conney A. H., Kappas A. I.: Nutritional influences on chemical biotransformation in humans. Nutr. Rev. 1992, 40, 161-168.
• 3.Anderson K. E., Kappas A., Conney A. H., Bradlow H. L., Fishman J.: The influence of dietary protein and carbohydrate on the principal oxidative biotransformation of estaradiol in normal subjects. J. Clin. Endocrinol. Metab. 1984, 59, 103-108.
• 4.Anderson K. E.: Influence of diet and nutrition on clinical pharmacokinetics. Clin. Pharmacokinet. 1998, 14, 325-331.
• 5.Antoszek J., Janus K., Muszczyński Z.: Dostępność biologiczna antypiryny u cieląt w pierwszych dwóch miesiącach życia. Medycyna Wet. 1999, 55, 123-125.
• 6.Bidlack W. R., Brown R. C., Mohan C.: Nutritional parameters that alter hepatic drug metabolism, conjugation and toxicity. Fed. Proc. 1986, 45, 142-146.
• 7.Boyd E. M.: Benzylpenicillins toxicity in albino rats fed synthetic high starch versus high sugar diets. Chemotherapy 1980, 15, 1-6.
• 8.Campbell T. C., Hayes J. R.: Role of nutrition in the drug metabolizing enzyme system. Pharmacol. Rev. 2004, 24, 171-180.
• 9.Depelchin B. O., Bloden S., Mitchaux C., Ansay M.: Effect of age sex and breed on antipyrine disposition in calves. Res. Vet. Sci. 1998, 44, 135-138.
• 10.Dickerson J. W. T., Basu T. K., Parke D. V.: Activity of drug metabolizing enzymes in the liver of growing rats fed diet high sucrose, glucose and fructose. Proc. Natur. Soc. 1991, 30, 27-32.
• 11.Elsheikh H. A., Ali B. H., Homeida A. M., Hassan T., Hapke H. J.: Pharmacokinetics of antipyrine and sulphadimidine (sulfamethazine) in camels, sheep and goats. J. Vet. Pharmacol. Ther. 1991, 14, 269-275.
• 12.Engel G., Hofmann U., Heidemann H., Cosme J., Eichelbaum M.: Antipyrine as a probe for human oxidative drug metabolism: Identification of the cytochrome P-450 enzymes catalyzing 4-hydroxyantipyrine, 3-hydroxymethylantipyrine and norantipyrine formation. Clin. Pharmacol. Ther. 1996, 59, 613-622.
• 13.Feldman G. H., Hutchinson V. E., Pippenger C. E., Blumenfeld T. A., Feldman B. R., Davis W. J.: Effect of dietary protein and carbohydrate on theophylline metabolism in children. Pediatrics. 1980, 66, 956-960.
• 14.Ferre I., Lopez P., Rojo-Vasquez F. A., Gonzales-Gallego J.: Experimental ovine fasciolosis; antipyrine clearence as indicator of liver damage. Vet. Parasitol. 1996, 62, 93-96.
• 15.Gawrońska-Szklarz B.: Klasyfikacja enzymów mikrosomalnych cytochromu P-450. Probl. Ter. Monit. 1995, 6, 159-165.
• 16.Hartleb M.: Drug and the liver. Part. II. The role of antypiryne test in drug metabolism studies. Biopharm. Drug Disp. 2001, 12, 559-571.
• 17.Hartshorn R. D., Demers L. M., Sultatos L. G., Vesell E. S., Lang M. C., Hughes H. C.: Effect of chronic parenteral carbohydrate administration on hepatic drug metabolism in the rat. Pharmacology 1989, 18, 103-108.
• 18.Janus K.: Makroskładniki diety a biotransformacja wątrobowa. Żyw. Człow. Metab. 1994, 21, 293-300.
• 19.Janus K., Antoszek J.: The effect of sex on antipyrine metabolism in cattle at different ages. J. Vet. Pharmacol. Ther. 1999, 22, 163-169.
• 20.Janus K., Suszycka J., Muszczyński Z.: Dobowe zmiany szybkości biotransformacji antypiryny u cieląt. Medycyna Wet. 1998, 54, 314-317.
• 21.Janus K., Królak J., Antoszek J., Suszycki S., Grochowina B., Muszczyński Z.: Dobowe zmiany farmakokinetyki antypiryny u cieląt żywionych dietą bogatobiałkową. Medycyna Wet. 2004, 60, 886-889.
• 22.Jiang S. X., Bayon J. E., Ferre I., Mao X. Z., Gonzalez-Gallego J.: Effect of experimental fasciolosis on antipyrine metabolism and clearance in water buffaloes. Vet. Parasitol. 2000, 88, 177-180.
• 23.Kalow W.: Genetic variation in human hepatic cytochrome P-450 system. Eur. J. Clin. Pharmacol. 1997, 31, 633-649.
• 24.Kappas A., Anderson K. E., Conney A. H., Alvares A. P.: Influence of dietary protein and carbohydrate on antipyrine and theophylline metabolism in man. Clin. Pharmacol. Ther. 1986, 20, 643-647.
• 25.Klinger W.: Biotransformation of drugs and other xenobiotics during postnatal development. Pharmacol. Therap. 1998, 16, 377-401.
• 26.Konig P. K., Cantilena L.: Antipyrine as a model drug substance to assess oxidative metabolism. Arch. Int. Med. 1994, 154, 590-594.
• 27.Offiah V. N., Nijmeijer S. M., Duin C. T., Witkamp R. F., Van Miert A. S.: Effect of triiodothyronine treatment on pharmacokinetics properties and metabolite formation of antipyrine in dwarf goats. Am. J. Vet. Res. 1992, 53, 1354-1357.
• 28.Pantuck E. J., Pantuck C. B., Kappas A.: Effects of protein and carbohydrate content of diet on drug conjugation. Clin. Pharmacol. Ther. 1991, 50, 254-257.
• 29.Peraino C., Lamar C., Pitot H. C.: Studies on mechanism of carbohydrate repression in rat liver. Adv. Enzyme Regul. 1996, 4, 199-205.
• 30.Piroli R. J.: Influence of dietary protein and carbohydrate on oxidative biotransformation of drugs in normal adults and children with asthma. Nutr. Rev. 1991, 39, 232-238.
• 31.Scholtens E., Basra A. J., Mulder G. J.: Effect of variation in the dietary supply of glucose on liver concentrations of glutathione and active sulfate: relation to the metabolism of acetaminophen. J. Nutr. 1993, 113, 1363-1366.
• 32.Strother A., Throckmorton J. K., Herzer C.: The influence of high sugar consumption by mice on the duration of action of barbiturates and "in vitro" metabolism of barbiturates, aniline and p-nitroanisole. J. Pharmacol. Exp. Ther. 1991, 179, 490-495.
• 33.Wasfi I. A., Boni N. S., Elghazali M., Alkatheeri N. A., Abdel Hadi A. A., Al Muharami A. M., Berazaig I. M.: Lack of effect of repeated administration of tripelennamine on antipyrine disposition in camels. J. Vet. Pharmacol Ther. 2000, 23, 409-412.
• 34.Witkamp R. F., Nijmeijer S. M., Kolker H. J., Noordhoek J., Van Miert A. S.: Effect of gonadal hormones on the plasma clearance and metabolite formation of antipyrine in the dwarf goat. J. Vet. Pharmacol. Ther. 1993, 16, 164-169.